These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1372861)

  • 21. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A newer immunoglobulin intravenous (IGIV) - Gammagard liquid 10%: evaluation of efficacy, safety, tolerability and impact on patient care.
    Shah SR
    Expert Opin Biol Ther; 2008 Jun; 8(6):799-804. PubMed ID: 18476791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects of human immunoglobulin therapy.
    Stiehm ER
    Transfus Med Rev; 2013 Jul; 27(3):171-8. PubMed ID: 23835249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The product: All intravenous immunoglobulins are not equivalent.
    Siegel J
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):78S-84S. PubMed ID: 16229678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.
    Mahadevia PJ
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):94S-100S. PubMed ID: 16229680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases.
    De Ranieri D; Fenny NS
    Pediatr Ann; 2017 Jan; 46(1):e8-e12. PubMed ID: 28079912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Indications for intravenous immunoglobulins].
    Mouthon L
    Presse Med; 2006 Apr; 35(4 Pt 2):714-9. PubMed ID: 16614620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Established and new uses of intravenous immunoglobulin.
    Cunningham-Rundles C
    Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes.
    Schwartz SA
    Clin Rev Allergy; 1992; 10(1-2):1-12. PubMed ID: 1606517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of the biochemistry and safety of a new native intravenous gamma globulin, IGIV, pH 4.25.
    Schwartz RS
    Am J Med; 1987 Oct; 83(4A):46-51. PubMed ID: 3118708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New approaches in the therapy of immunodeficiency.
    Fleisher TA; Blaese RM
    Allergy Proc; 1993; 14(6):409-11. PubMed ID: 8157164
    [No Abstract]   [Full Text] [Related]  

  • 35. [Regulation of autoreactivity by the idiotypic network and therapeutic modulation of autoimmunity by polyvalent intravenous immunoglobulins (IgIV)].
    Lacroix-Desmazes S; Kaveri S; Kazatchkine MD
    Rev Neurol (Paris); 1996 May; 152(5):349-54. PubMed ID: 8881428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and patient acceptability of intravenous immune globulin in 10% maltose.
    Ochs HD; Buckley RH; Pirofsky B; Fischer SH; Rousell RH; Anderson CJ; Wedgwood RJ
    Lancet; 1980 Nov; 2(8205):1158-9. PubMed ID: 6107768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
    McCormack PL
    BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supply, use, and abuse of intravenous immunoglobulin.
    Nowak-Wegrzyn A; Lederman HM
    Curr Opin Pediatr; 1999 Dec; 11(6):533-9. PubMed ID: 10590912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Old and current aspects of intravenous immunoglobulin therapy].
    Nydegger U
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases].
    Klein M; Kaminsky P; Duc M
    Therapie; 1993; 48(2):97-103. PubMed ID: 8351694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.